December 10, 2021
Jeffrey
Gabor
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F. Street, NW
Washington, D.C. 20549
Re: | Genenta Science S.p.A. | |
Registration Statement on Form F-1 | ||
File No. 333-260923 | ||
Registration Statement on Form 8-A | ||
File No. 001-41115 |
Dear Mr. Gabor:
The Company hereby requests, pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, acceleration of the effectiveness of the above-referenced filings so that such registration statements will become effective as of 5:00pm on Tuesday, December 14, 2021, or as soon thereafter as practicable. By separate letter, the underwriter for the issuance of the securities being registered join in this request.
Sincerely, | |
/s/ Richard B. Slansky | |
Richard B. Slansky, Chief Financial Officer |